Toronto, Ont., - Rna Diagnostics, a Canadian cancer diagnostics company, is pleased to announce the results from phase 1 of the BREVITY (Breast Cancer Response Evaluation for Individualized Therapy) clinical trial – that aims to validate the utility of the RNA...